On October 14, 7NEWS ran a commission-linked feature on BYOMA’s Longevit-8 Peptide Serum, $42 at Sephora Australia, headlined with a line its page never attributes: ‘I’m already starting to notice results’. The headline’s last words carry the sale, and they belong to no one. The 7NEWS page never says who noticed results, and the line does not appear in the article below it. The only person the page names and quotes is BYOMA founder Marc Elrick. One unsigned sentence is quoted as the verdict on a product, a single line made to stand for the whole. A plain headline would have said: a $42 serum is on sale at Sephora Australia, and its maker says it works. Around that line, the crowd does the proving. The page credits its ‘frenzy’ and ‘no needle’ descriptions to unnamed shoppers, so the mind hears that everyone already agrees. The ‘no-needle’ wording is in BYOMA’s own launch caption. The store’s count is smaller: 6 reviews. The page closes with ‘act fast before it sells out’, under a note that 7NEWS may earn a commission. The tell to keep: a quote in a headline with no name attached, and a buy link under it. The promise is thinner than the headline. BYOMA’s collagen figures come from cells in a dish over 24 hours, its own footnote says. The ‘up to 85%’ wrinkle figure is the best of 39 volunteers over two weeks. BYOMA says its study is being submitted for peer review, so no one outside could read it when 7NEWS ran. No dermatologist speaks on the page, about peptides or about PDRN on the skin. The same bottle sells for £21.99 in Britain.
